NM_001110792.2:c.942C>G

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_001110792.2(MECP2):​c.942C>G​(p.Pro314Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000231 in 1,210,687 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. P314P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000098 ( 0 hom., 1 hem., cov: 23)
Exomes 𝑓: 0.000015 ( 0 hom. 2 hem. )

Consequence

MECP2
NM_001110792.2 synonymous

Scores

9

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.367

Publications

2 publications found
Variant links:
Genes affected
MECP2 (HGNC:6990): (methyl-CpG binding protein 2) DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. In contrast to other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of cognitive disability in females. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2015]
MECP2 Gene-Disease associations (from GenCC):
  • chromosome Xq28 duplication syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • Rett syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen, G2P
  • severe neonatal-onset encephalopathy with microcephaly
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • syndromic X-linked intellectual disability Lubs type
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • atypical Rett syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked intellectual disability-psychosis-macroorchidism syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • systemic lupus erythematosus
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.056803882).
BP6
Variant X-154030922-G-C is Benign according to our data. Variant chrX-154030922-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 143739.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154030922-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 143739.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154030922-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 143739.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154030922-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 143739.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154030922-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 143739.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154030922-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 143739.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154030922-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 143739.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154030922-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 143739.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154030922-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 143739.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154030922-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 143739.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154030922-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 143739.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154030922-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 143739.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154030922-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 143739.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154030922-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 143739.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154030922-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 143739.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.367 with no splicing effect.
BS2
High AC in GnomAd4 at 11 XL,Unknown,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MECP2NM_001110792.2 linkc.942C>G p.Pro314Pro synonymous_variant Exon 3 of 3 ENST00000453960.7 NP_001104262.1 P51608-2A0A140VKC4Q59FJ6
MECP2NM_004992.4 linkc.906C>G p.Pro302Pro synonymous_variant Exon 4 of 4 ENST00000303391.11 NP_004983.1 P51608-1D3YJ43Q59FJ6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MECP2ENST00000453960.7 linkc.942C>G p.Pro314Pro synonymous_variant Exon 3 of 3 1 NM_001110792.2 ENSP00000395535.2 P51608-2
MECP2ENST00000303391.11 linkc.906C>G p.Pro302Pro synonymous_variant Exon 4 of 4 1 NM_004992.4 ENSP00000301948.6 P51608-1

Frequencies

GnomAD3 genomes
AF:
0.0000979
AC:
11
AN:
112413
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.000355
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000490
AC:
9
AN:
183501
AF XY:
0.0000147
show subpopulations
Gnomad AFR exome
AF:
0.000684
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000155
AC:
17
AN:
1098222
Hom.:
0
Cov.:
35
AF XY:
0.00000550
AC XY:
2
AN XY:
363578
show subpopulations
African (AFR)
AF:
0.000530
AC:
14
AN:
26402
American (AMR)
AF:
0.00
AC:
0
AN:
35207
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19386
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30206
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54145
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40528
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4137
European-Non Finnish (NFE)
AF:
0.00000119
AC:
1
AN:
842113
Other (OTH)
AF:
0.0000434
AC:
2
AN:
46098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000978
AC:
11
AN:
112465
Hom.:
0
Cov.:
23
AF XY:
0.0000289
AC XY:
1
AN XY:
34631
show subpopulations
African (AFR)
AF:
0.000354
AC:
11
AN:
31031
American (AMR)
AF:
0.00
AC:
0
AN:
10729
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2647
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3562
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2748
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6162
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53153
Other (OTH)
AF:
0.00
AC:
0
AN:
1528
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000434
Hom.:
0
Bravo
AF:
0.0000756
ESP6500AA
AF:
0.000522
AC:
2
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000659
AC:
8

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Severe neonatal-onset encephalopathy with microcephaly Benign:1
Apr 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Nov 01, 2007
RettBASE
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:curation

- -

Rett syndrome Benign:1
Mar 18, 2024
Centre for Population Genomics, CPG
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:curation

This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as benign. At least the following criteria are met: The allele frequency of this variant in at least one population in gnomAD is higher than the 0.03% threshold defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders VCEP 3.0 (BA1). -

MECP2-related disorder Benign:1
Jun 03, 2024
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
6.2
DANN
Benign
0.72
DEOGEN2
Benign
0.064
T
FATHMM_MKL
Benign
0.30
N
LIST_S2
Benign
0.21
T
MetaRNN
Benign
0.057
T
PhyloP100
-0.37
Sift4G
Benign
1.0
T
Vest4
0.50
MVP
0.96
GERP RS
3.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61751438; hg19: chrX-153296373; API